Novel Heterocyclic Compounds for Treating Huntington's Disease.


Journal

ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 28 01 2024
pmc-release: 14 03 2025
medline: 20 3 2024
pubmed: 20 3 2024
entrez: 20 3 2024
Statut: epublish

Résumé

Provided herein are novel heterocyclic compounds, pharmaceutical compositions, use of such compounds in treating Huntington's disease, and processes for preparing such compounds.

Identifiants

pubmed: 38505841
doi: 10.1021/acsmedchemlett.4c00045
pmc: PMC10945529
doi:

Types de publication

Editorial

Langues

eng

Pagination

324-325

Informations de copyright

Published 2024 by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Auteurs

Ram W Sabnis (RW)

Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.

Anika R Sabnis (AR)

Neuroscience Institute, Georgia State University, Atlanta, Georgia 30303, United States.

Classifications MeSH